Algernon Pharmaceuticals Competitors and Similar CompaniesClear all
Algernon Pharmaceuticals's competitors and similar companies include Biogen.
 Algernon Pharmaceuticals Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Vancouver, CA HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees N/A | Employees 7,605 |
Valuation ($) | Valuation ($) 1.6 m | Valuation ($) 26.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($1.7m) (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company